BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 11:02:00 AM | Browse: 1151 | Download: 1048
 |
Received |
|
2013-10-06 17:32 |
 |
Peer-Review Started |
|
2013-10-07 10:54 |
 |
To Make the First Decision |
|
2013-12-16 17:38 |
 |
Return for Revision |
|
2013-12-17 19:24 |
 |
Revised |
|
|
 |
Second Decision |
|
2014-01-15 20:14 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-01-15 20:28 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-03-11 09:08 |
 |
Publish the Manuscript Online |
|
2014-03-27 12:04 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment
|
Manuscript Source |
Invited Manuscript |
All Author List |
Alfredo Papa, Viviana Gerardi, Manuela Marzo, Carla Felice, Gian Lodovico Rapaccini and Antonio Gasbarrini |
Funding Agency and Grant Number |
|
Corresponding Author |
Alfredo Papa, MD, Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Catholic University, Via G. Moscati 31-33, 00168 Rome, Italy. apapa@rm.unicatt.it |
Key Words |
Inflammatory bowel disease; Venous thromboembolism; Thromboembolic prophylaxis; Anticoagulants; Unfractionated heparin; Low molecular weight heparin |
Core Tip |
Inflammatory bowel diseases (IBD) patients have an increased risk of venous thromboembolism (VTE) that represents a significant cause of morbidity and mortality. The prevention of VTE involves the correction of modifiable risk factors, such as: disease activity, vitamin deficiency, dehydration and prolonged immobilization. Essential is also the role of mechanical and pharmacological prophylaxis. However, thromboprophylaxis in IBD patients, although guideline-recommended is still poorly implemented because of concerns about its safety and, over all, the lack of awareness of the magnitude of thrombotic risk in these patients. Further efforts are required to increase the rate of pharmacological prevention of VTE in IBD so to avoid some preventable morbidity and mortality. |
Publish Date |
2014-03-27 12:04 |
Citation |
Papa A, Gerardi V, Marzo M, Felice C, Rapaccini GL, Gasbarrini A. Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment. World J Gastroenterol 2014; 20(12): 3173-3179 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i12/3173.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i12.3173 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345